Cart
sales@molnova.com
N6-Ethyladenosine
CAS No. 14357-08-5
N6-Ethyladenosine( —— )
Catalog No. M26318 CAS No. 14357-08-5
N6-Ethyladenosine is an adenosine derivative, acts as an agonist of Adenosine receptor(hA1AR and hA3AR with Kis of 4.9 and 4.7 nM , respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 52 | In Stock |
|
| 5MG | 30 | In Stock |
|
| 10MG | 48 | In Stock |
|
| 25MG | 88 | In Stock |
|
| 50MG | 145 | In Stock |
|
| 100MG | 214 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN6-Ethyladenosine
-
NoteResearch use only, not for human use.
-
Brief DescriptionN6-Ethyladenosine is an adenosine derivative, acts as an agonist of Adenosine receptor(hA1AR and hA3AR with Kis of 4.9 and 4.7 nM , respectively).
-
DescriptionN6-Ethyladenosine is an adenosine derivative, acts as an agonist of Adenosine receptor(hA1AR and hA3AR with Kis of 4.9 and 4.7 nM , respectively).(In Vitro):N6-Ethyladenosine exhibits more selectivity at hA1AR and hA3AR over hA2AR with Ki of 8900±770 nM .
-
In VitroN6-Ethyladenosine (Compound 28) exhibits more selectivity at hA1AR and hA3AR over hA2AR (Ki, 8900±770 nM).
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetAdenosine Receptor
-
RecptorCYP3A4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number14357-08-5
-
Formula Weight295.299
-
Molecular FormulaC12H17N5O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 83.33 mg/mL (282.20 )
-
SMILESCCNc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lin CC, et al. Metabolic activation of Pradefovir by CYP3A4 and its potential as an inhibitor or inducer. Antimicrob Agents Chemother. 2006 Sep;50(9):2926-31.
molnova catalog
related products
-
Adenosine A1 recepto...
Adenosine A1 receptor activator T62 is an allosteric enhancer of adenosine A1 receptor, and it produces antinociception in animal models of acute pain and also reduces hypersensitivity in models of inflammatory and nerve-injury pain[2][3].
-
KI-7
KI-7 is an adenosine A2B receptor positive allosteric modulator.
-
PSB 1115
PSB 1115 is an A2B receptor antagonist and can counteract the inhibitory effect of NECA.
